Yilong Yan
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
New Drug Approvals in China: An International Comparative Analysis, 2019-2023.
Journal: Drug design, development and therapy
Published: December 24, 2024
Cardiovascular outcomes of urate-lowering therapies in patients with gout or hyperuricemia: a network meta-analysis.
Journal: Expert opinion on drug safety
Published: November 14, 2024
Evidence-based recommendations for the prophylactic use of antiseizure medications (ASMs) in neurosurgery: a systematic review of guidelines.
Journal: Journal of neurology
Published: September 18, 2024
Comparative efficacy and safety of first‑line PD‑1/PD‑L1 inhibitors in immunotherapy for non‑small cell lung cancer: A network meta‑analysis.
Journal: Oncology letters
Published: September 13, 2024
Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS).
Journal: BMC pharmacology & toxicology
Published: September 12, 2024
Utilization of glucagon-like peptide-1 receptor agonists in children and adolescents in China: a real-world study.
Journal: Frontiers in endocrinology
Published: February 20, 2023
Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China.
Journal: Frontiers in endocrinology
Published: July 05, 2022
Comparison of varying operating parameters on heavy metals ecological risk during anaerobic co-digestion of chicken manure and corn stover.
Journal: Bioresource technology
Published: July 26, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026